• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Synthetic Biology

Synthetic gene circuits pump up cell signals

Bioengineer by Bioengineer
April 8, 2014
in Synthetic Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Synthetic genetic circuitry created by researchers at Rice University is helping them see, for the first time, how to regulate cell mechanisms that degrade the misfolded proteins implicated in Parkinson’s, Huntington’s and other diseases.

Synthetic gene circuits pump up cell signals

From left, graduate student Wenting Zhao, bioengineer Laura Segatori and graduate student Claire McWhite. Photo Credits: Jeff Fitlow

The Rice lab of chemical and biomolecular engineer Laura Segatori has designed a sophisticated circuit that signals increases in the degradation of proteins by the cell’s ubiquitin proteasome system (UPS).

The UPS is essential to a variety of fundamental cellular processes, including the cell cycle, DNA repair, immune response, cell death and the degradation of misfolded and damaged proteins. It has several components: ubiquitin molecules that tag misfolded proteins for degradation and proteasomes that latch onto the tagged proteins and break them down into harmless peptides.

When there are too few proteasomes in a cell, or they don’t function properly, misfolded proteins that remain floating in the cytoplasm can aggregate. These aggregates can form plaques, as often seen in the brains of people with neurodegenerative diseases.

The Rice team added to the cell a set of genetic circuits called Degradation On – “Deg-On” for short. These circuits produce a green fluorescent signal linked to UPS degradation and allow the researchers to monitor proteasomal activity.

“The overall goal is to develop a technology to screen for molecules that would enhance or activate degradation,” said Segatori, Rice’s T.N. Law Assistant Professor of Chemical and Biomolecular Engineering and an assistant professor of biochemistry and cell biology.

“The proteasome is essentially a big barrel that unfolds and chops up misfolded proteins. We know how to inhibit degradation, but we want to find ways to activate it, because we think that will be useful to help prevent accumulation of misfolded proteins and aggregation, which are associated with the development of a number of human diseases.”

The Deg-On circuit couples proteasomal degradation of an engineered tetracycline repressor to an easily detectable fluorescent signal. The tetracycline repressor is engineered to function as a UPS substrate; it essentially mimics a misfolded protein.

Normally, enhanced degradation would dampen the output signal, but this genetic circuit makes it possible to link enhanced degradation to an increase in output. The engineered repressor can still be regulated by the antibiotic tetracycline, which allows calibrating the system for the detection of even minimal activation of UPS degradation. An additional synthetic circuit provides a feedback loop that enables the self-amplification of the repressor so that adding tetracycline further boosts the signal.

The Rice team did extensive computer modeling of Deg-On to improve its sensitivity and dynamic range before building and testing the system on lab-standard HeLa cells. The team included graduate student and lead author Wenting Zhao, undergraduate Claire McWhite and Rice alumnus Matthew Bonem, in collaboration with Jonathan Silberg, an associate professor of biochemistry and cell biology at Rice.

“We came up with the idea of having a feedback loop, which is a self-activation loop for the tetracycline repressor, in our second circuit (an enhanced Deg-On),” Zhao said. “We found that a small increase in UPS activity caused a small decrease in the TetR repressor protein. Because TetR activates its own expression in the enhanced Deg-On, the fluorescent output signal is amplified and the circuit gains in sensitivity and dynamic range.”

“Wenting’s work was instrumental in predicting changes in the circuit architecture that would lead to enhanced sensitivity,” Segatori said.

The lab’s immediate goal is to create assays for the rapid detection of small molecules or genes that can increase proteasomal activity, she said. “This will help us rationally design compounds or strategies that could enhance degradation not only for the study and treatment of misfolding diseases but also for a variety of other applications.

“Misfolding and aggregation are among the main challenges in the fields of bioengineering and biotechnology. They are the bottleneck in the high-yield production of recombinant proteins, for example, in cells engineered to crank up expression of a protein of interest,” Segatori said.

Story Source:

The above story is based on materials provided by Rice University, Mike Williams.

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Democratizing synthetic biology

March 2, 2015
blank

A new path for novel synthetic polio vaccine

February 17, 2015

New class of synthetic molecules mimics antibodies

December 19, 2014

Synthetic Molecule Makes Cancer Self-Destruct

August 12, 2014
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Developing Neonatal Point-of-Care Ultrasound Programs

DCAF13 Crucial for Mouse Uterine Function, Fertility

Machine Learning Transforms Immunotherapy in Metastatic NSCLC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.